Compliance and Trust
Medigize takes a compliance-first approach. Compliance is not treated as an afterthought or a legal overlay, but as part of how the platform is designed to operate: what is collected, what is not collected, how data is handled, where the platform's role stops, and where licensed provider responsibility begins.
How to understand compliance here
Medigize does not treat compliance as legal text alone, but as part of operating design:
data minimization
no PHI collection through the public website
clear role boundaries
assistive and governed AI use
auditable and accountable workflows
Reference frameworks
What this means practically
- 1
The public website does not collect health records, diagnoses, test results, payment data, government ID, or biometrics.
- 2
Permitted data is used strictly for inquiry handling, communication, and experience improvement under the applicable legal basis.
- 3
AI use within Medigize is assistive and governed, not autonomous in high-risk decisions.
- 4
Diagnoses, treatments, and final clinical decisions remain the responsibility of licensed healthcare professionals.
- 5
Trust and quality layers are built around transparency, clarity, discipline, and the avoidance of unsupported claims.
Accessibility Statement
Medigize is committed to ensuring digital accessibility for people with disabilities. We are continually improving the user experience for everyone and applying the relevant accessibility standards.
The Web Content Accessibility Guidelines (WCAG) defines requirements for designers and developers to improve accessibility for people with disabilities. Medigize is built to target WCAG 2.2 Level AA conformance. This includes considerations for color contrast, semantic HTML, keyboard navigability, and clear focus indicators.
As an MVP in development, we recognize that some areas may not be fully accessible yet, particularly as new dynamic components are introduced. We consider accessibility to be a continuous process.
If you experience any difficulty accessing our website, please contact us.


